Meiiji Seika Acquires 100% Of Medriech For $290 Million
This article was originally published in PharmAsia News
Executive Summary
Meiiji Seika has acquired all of Medriech in a friendly takeover valued at $290 million, giving the Japan drug maker access to the India company's branded generics of major drugs.